CIBC Innovation Banking Provides Growth Capital to EnsoData
EnsoData is advancing sleep medicine through AI-powered, FDA-cleared solutions that help simplify diagnosis and expand access to care. Its flagship product, EnsoHST, is a clinically proven, multi-night home sleep testing solution that uses a simple wearable device and mobile app to deliver fast, clinically reliable results. By automating analysis and removing operational friction, EnsoData enables clinicians to expand capacity, accelerate diagnosis, and improve patient outcomes.
"This facility from CIBC Innovation Banking enables EnsoData to expand access to the sleep care pathway today, while accelerating our investment in AI-driven innovations that will shape the future of diagnostics across multiple clinical domains," said
"CIBC Innovation Banking is very glad to support EnsoData’s growth and continued adoption among sleep medicine professionals,” said
About CIBC Innovation Banking
CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across
About EnsoData
EnsoData is a healthcare technology company advancing sleep medicine through artificial intelligence. Its solutions support the full sleep care continuum, from diagnosis through long-term patient management, enabling clinicians to improve efficiency and expand access to care. EnsoData is also exploring applications across additional clinical areas. To date, EnsoData’s technology has supported the care of more than 2.9 million patients. https://ensodata.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260512709333/en/
Source: CIBC Innovation Banking